CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
NASDAQ · Healthcare · Biotechnology · SG
$3.16
+7.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.12x
- Price / sales
- 215.10x
- Price / cash flow
- -1.17x
Enterprise value
- Enterprise value
- $6.4M
- EV / sales
- 162.29x
- EV / EBITDA
- -1.78x
- EV / EBIT
- -1.77x
- Market cap
- $8.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025